Dg Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Dg Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $2.06 Million - $3.01 Million	25,908 Added 14.0%	210,961 $16.8 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $864,200 - $1.1 Million	10,000 Added 5.71%	185,053 $19.5 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $1.13 Million - $1.35 Million	-12,261 Reduced 6.55%	175,053 $19.2 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $862,400 - $959,200	10,000 Added 5.64%	187,314 $17.5 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $308,869 - $410,564	-4,300 Reduced 2.37%	177,314 $16.3 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $8.82 Million - $11.1 Million	131,614 Added 263.23%	181,614 $13.3 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $2.76 Million - $4 Million	50,000 New	50,000 $3.88 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dg Capital Management, LLC with notifications on news.